[ APPLICATION NOTE ] Development of a Hybrid Immunoaffinity-LC-MS/MS Method for the Quantification of Active Biotherapeutics Targeting TNF-α in Serum Caitlin Dunning and Mary Lame Waters Corporation, Milford, MA, USA APPLICATION BENEFITS ■■ ■■ High analytical sensitivity Tumor Necrosis Factor…
Key words
infliximab, immunoaffinity, nylawyqqkpgk, adalimumab, sinsathyaesvk, biotherapeutics, etanercept, ictcrpgwycalsk, tnf, quantification, serum, hybrid, apytfgqgtk, active, dilltqspailsvspger